Benjamin Edwards Inc Abb Vie Inc. Transaction History

Benjamin Edwards Inc

$6.71 Billion
Q3 2024

A detailed history of Benjamin Edwards Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Benjamin Edwards Inc holds 335,966 shares of ABBV stock, worth $59 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

335,966

Previous 37,644 792.48%

Holding current value

$59 Million

Previous $6.46 Million 927.51%

% of portfolio

0.99%

Previous 1.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $48.9 Million - $59.5 Million	298,322 Added 792.48%	335,966 $66.3 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $806,765 - $942,121	-5,212 Reduced 12.16%	37,644 $6.46 Million
Q1 2024 Apr 29, 2024	BUY	$159.82 - $182.1 $455,646 - $519,167	2,851 Added 7.13%	42,856 $7.8 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $602,137 - $678,148	4,376 Added 12.28%	40,005 $6.2 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $19,370 - $22,424	145 Added 0.41%	35,629 $5.31 Million
Q2 2023 Aug 15, 2023	BUY	$132.51 - $164.9 $571,250 - $710,883	4,311 Added 13.83%	35,484 $4.78 Million
Q1 2023 Apr 27, 2023	BUY	$144.61 - $166.54 $526,091 - $605,872	3,638 Added 13.21%	31,173 $4.97 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $95,987 - $115,113	694 Added 2.59%	27,535 $4.45 Million
Q3 2022 Oct 28, 2022	BUY	$134.21 - $153.93 $63,212 - $72,501	471 Added 1.79%	26,841 $3.6 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $19,817 - $25,194	-144 Reduced 0.54%	26,370 $4.04 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $1.45 Million - $1.79 Million	10,961 Added 70.48%	26,514 $4.3 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $1.52 Million - $1.92 Million	14,157 Added 1014.11%	15,553 $2.11 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $73,735 - $83,700	693 Added 98.58%	1,396 $151,000
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $1,893 - $2,109	18 Added 2.63%	703 $79,000
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $6,342 - $6,982	62 Added 9.95%	685 $74,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $3,944 - $5,324	-49 Reduced 7.29%	623 $67,000
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $515 - $604	6 Added 0.9%	672 $59,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $4,842 - $6,479	-66 Reduced 9.02%	666 $65,000
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $12,126 - $18,384	188 Added 34.56%	732 $56,000
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $10,386 - $12,996	144 Added 36.0%	544 $48,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $30,856 - $36,316	400 New	400 $32,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account

Benjamin Edwards Inc Abb Vie Inc. Transaction History